Combining Aplidin (plitidepsin) with dexamethasone significantly extends their survival in heavily pretreated multiple myeloma patients compared to dexamethasone alone, data…
Stacy Grieve, PhD
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Stacy Grieve, PhD
A combination of Pomalyst (pomalidomide) and low-dose dexamethasone is cheaper than either Darzalex (daratumumab) or Kyprolis (carfilzomib) alone as…
A new study reports that the specific type of multiple myeloma (MM) may affect how long the drug Darzalex (daratumumab)…
MYELOMA
Kyprolis Combo Treatment Extends Survival of Relapsed Myeloma Patients, ENDEAVOR Study Shows
Relapsed multiple myeloma patients who receive Kyprolis (carfilzomib) plus dexamethasone as their second-to-fourth treatment regimen survive a median of…